ajit johnson nirmal
Brigham and Women's Hospital, Harvard Medical School
Boston, United States
Review Editor
Cancer Immunity and Immunotherapy
Brigham and Women's Hospital, Harvard Medical School
Boston, United States
Review Editor
Cancer Immunity and Immunotherapy
Osaka University
Suita, Japan
Review Editor
Cancer Immunity and Immunotherapy
Osaka City University
Osaka, Japan
Review Editor
Cancer Immunity and Immunotherapy
Loyola University Medical Center
Maywood, United States
Review Editor
Cancer Immunity and Immunotherapy
Cancer Immunology and Immunotherapy Unit, Research and Advanced Technologies Department, Regina Elena National Cancer Institute (IRCCS)
Rome, Italy
Review Editor
Cancer Immunity and Immunotherapy
Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences
Beijing, China
Review Editor
Cancer Immunity and Immunotherapy
University of Pennsylvania
Philadelphia, United States
Review Editor
Cancer Immunity and Immunotherapy
INSERM U1068 Centre de Recherche en Cancérologie de Marseille (CRCM)
Marseille, France
Review Editor
Cancer Immunity and Immunotherapy
Icahn School of Medicine at Mount Sinai
New York, United States
Review Editor
Cancer Immunity and Immunotherapy
Alexander Fleming Specialized Medical Institute
Buenos Aires, Argentina
Review Editor
Cancer Immunity and Immunotherapy
University of Bologna
Bologna, Italy
Review Editor
Cancer Immunity and Immunotherapy
Department of Hematology, Clinical Immunology and Infectious Diseeases, Graduate School of Medicine, Ehime University
Toon, Japan
Review Editor
Cancer Immunity and Immunotherapy
University of Navarra
Pamplona, Spain
Review Editor
Cancer Immunity and Immunotherapy
Newcastle University
Newcastle upon Tyne, United Kingdom
Review Editor
Cancer Immunity and Immunotherapy
Osaka University
Suita, Japan
Review Editor
Cancer Immunity and Immunotherapy
Hematology Service, Research Department, Hospital General de MĂ©xico Dr. Eduardo Liceaga
Mexico City, Mexico
Review Editor
Cancer Immunity and Immunotherapy